Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arteris (AIP) Liabilities and Shareholders Equity (2023 - 2025)

Arteris (AIP) has disclosed Liabilities and Shareholders Equity for 3 consecutive years, with $115.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 8.38% year-over-year to $115.0 million, compared with a TTM value of $428.0 million through Dec 2025, up 6.57%, and an annual FY2025 reading of $115.0 million, up 8.38% over the prior year.
  • Liabilities and Shareholders Equity was $115.0 million for Q4 2025 at Arteris, up from $107.7 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $115.0 million in Q4 2025 and bottomed at $96.4 million in Q2 2024.
  • Average Liabilities and Shareholders Equity over 3 years is $104.1 million, with a median of $104.5 million recorded in 2023.
  • The sharpest move saw Liabilities and Shareholders Equity fell 9.79% in 2024, then grew 10.9% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $102.8 million in 2023, then rose by 3.24% to $106.1 million in 2024, then grew by 8.38% to $115.0 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for AIP at $115.0 million in Q4 2025, $107.7 million in Q3 2025, and $106.9 million in Q2 2025.